Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.

Ting WangNeil McAuslaneWim G GoettschHubert G M LeufkensMarie L De Bruin

Published in: International journal of technology assessment in health care (2023)

This research brought together regulators, HTA agencies, companies to examine how they interact with one another. We propose measures of value and make recommendations on future evolution to enable better evidence generation and improve regulatory and HTA decision-making.

Keyphrases

transcription factor
decision making
current status
healthcare
public health
climate change
human health
mental health
clinical practice
single cell
health information
social media
clinical evaluation